Study Design. A prospective multicenter cohort study.
T he most common reason for spinal surgery in elderly people is lumbar spinal stenosis (LSS) with increasing rates by aging of the population. 1, 2 The natural history of mild and moderate LSS is favorable in one-third to half of the patients. 3 First-line treatment options of LSS are usually nonsurgical. A potential effect of physical therapy, orthotics, rehabilitation, exercise, pain killers/NSAIDs, education, heat and cold applications, and electrical nerve stimulation or alike find low evidence. 4 Epidural injections of a corticosteroid (ESI) seem however to provide short-term (2 weeks to 6 months) symptom relief in patients with neurogenic claudication or radiculopathy but with conflicting evidence regarding the long-term efficacy. 3 The number of epidural injections being performed is increasing, although the potential of severe adverse effects is not to be neglected. [5] [6] [7] According to the US Food and Drug Administration (FDA), the administration of corticosteroids in the epidural space is considered off-label use and its use should carefully follow guidelines. 3, [8] [9] [10] Surgical decompression usually follows failed conservative treatment and provides a long-term pain relief in a large percentage of patients. 3, 11 The perioperative morbidity, despite the advanced age of the average patient, seems relatively low. 12, 13 One of the potentially serious complications of spinal surgery is infection with an incidence of 0.7% to 12%. 14, 15 Compared with that, the infection rate after spinal injections is reported to be 1% to 2% but still with possible devastating consequences for the patient. 7, 16 The immunosuppressive effect of corticosteroids is well known. [17] [18] [19] [20] Although frequently used in the treatment of LSS, ESI prior or even during surgery has not been sufficiently acknowledged or investigated as a potential risk factor for a postoperative SSI. 21, 22 Yang et al. 21 published very recently a retrospective analysis of a database with 18,931 patients; the patients were assigned to one of the following groups: Lumbar epidural steroid injections within 0 to 1 month, 1 to 3 months, 3 to 6 months, or 6 to 12 months between injection and surgery. 21 They identified patients with injection 0 to 1 and 1 to 3 months before surgery at a higher risk for postoperative infections. However, as the retrospective analyses originate from data of a large heterogeneous database, the potential of indication and selection bias is considered high and more clinically granular research was suggested by the editors.
The aim of this study was to evaluate the risk for surgical site infections (SSIs) or wound healing problems (WHPs) in patients who received a local corticosteroid injection before lumbar decompression surgery with or without fusion using a very detailed prospectively established national multicenter database. If so, the minimal time interval between injection and surgical intervention could be defined to minimalize the risk of SSIs or WHPs.
METHODS
The Lumbar Stenosis Outcome Study (LSOS), an ongoing, prospective, multicenter cohort with patients recruited from several hospitals in Switzerland, was used. 23 This multicenter cohort study was conducted in compliance with all international laws and regulations as well as any applicable guidelines. Written informed consent to participate in the study has been obtained from participants. The study was approved by the independent Ethics Committee of the Canton Zurich (KEK-ZH-NR: 2010-0395/ 0). Inclusion criteria for the cohort were symptomatic LSS with unilateral or bilateral neurogenic claudication, age of 50 years or older, and radiographically verified spinal stenosis [computed tomography (CT) or magnetic resonance imaging]. Further, the life expectancy had to be more than 1 year and the patients had to be available for follow-up during at least 1 year. Exclusion criteria for the cohort were a cauda equina syndrome requiring urgent surgery, acute fracture, infection or significant deformity (>158 lumbar scoliosis), and a clinically relevant peripheral arterial disease. A database query was performed on 743 patients to identify the case group with patients with a SSI or a WHP after primary decompression and/or fusion for LSS who underwent revision surgery for that reason.
These patients of the case group were matched to a control group according to age and sex, and the presence of risk factors for postoperative infections in spine surgery such as diabetes and body mass index (BMI). According to a recent meta-analysis, a match for smoking status was abandoned, as it was not shown as an independent risk factor for SSI in spinal surgery. 24 The number of corticosteroid injections and time interval to surgery was determined. Injections to different regions or different levels on the same date (e.g., to the facet joints and epidural) were not discriminated. Intraoperative application of corticosteroid in surgical treatment of LSS is considered obsolete in Switzerland and therefore this potential bias was not monitored.
In addition, established clinical outcome score such as Symptom Severity Scale (SSM), Roland Morris Disability Questionnaire (RMDQ), Pain numeric rating scale (NRS), and EuroQol-5D (EQ-5D-3L) were determined for each of the subgroups at baseline and the last visit after 24 months.
The SSM, an instrument specifically developed and validated for spinal stenosis patients by Stucki et al., 25 targets to measure severity of symptoms and quantifies disability of the LSS population. [26] [27] [28] It consists of three different subscales; the symptom severity subscale, the physical function subscale, and the satisfaction with treatment results subscale with score ranges from 1 to 5 and 1 to 4 (best-worst). The Roland and Morris Disability Questionnaire is a back pain specific, self-rated physical disability questionnaire developed by Roland and Morris in 1983. 29 The maximum number of points is 24 and indicates severe disability. 30 The EQ-5D-3L is an assessment tool to measure healthrelated quality of life with five dimensions of health (mobility, self-care, usual activities, pain/discomfort, and anxiety/ depression), which can be calculated as a sum score (score range 0-100, worst-best).
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Statistical Analyses
The software ''R'' was used for the statistical analysis. 33 Descriptive statistics are reported as mean and standard deviations (SDs) for continuous variables and numbers and percentages of total for the categorical variables. A matched case-control study design was employed to address the influence of preoperative epidural injections on the rare event of SSI or WHP. Patients with infections or WHPs were defined as ''cases.'' Control patients were matched to the cases, if the variables age (AE2 years), gender, BMI (!30 kg/m 2 ), and diabetes were identical. A conditional logistic regression approach was used with the advantage that all available control patients could be included, that is, resulting in either one or more control patients for each case. Odds ratios (ORs) were calculated to quantify the effect of preoperative epidural infections on SSI or WHP; either overall, or within specified time periods up to 3 or 6 months before surgery. A P value of < 0.05 was defined as statistically significant.
RESULTS
Of 743 patients included in the LSOS cohort, 422 patients (57%) were treated with spinal surgery (Figure 1 ). Of those, a total of 10 patients (2.4%) underwent revision surgery either for SSI (n ¼ 6) or WHP (n ¼ 4) ( Table 1) .
Patients who were revised for a SSI had a mean age of 70.7 [standard deviation (SD) 10.5] years, a mean BMI of 29.5 (SD 4.3) kg/m 2 , and one-third were females. Only one of the patients (16.7%) had a reported diabetes mellitus.
Four of the six patients (66%) with SSI had injections before surgery (a total of 15 injections).
Patients who were revised for a WHP had a mean age of 65 (SD 4.2) years, mean of BMI 33.8 (SD 1.9) kg/m 2 , and three (75%) of the patients were female. Two (50%) of the patients had a reported diabetes mellitus. Only one patient (25%) had corticosteroid injections before surgery (a total of two injections) ( Table 1 (Table 1) .
Combining the SSI and WHP subgroup, the total amount of injections in the combined case group was five of 10 patients (50%) compared with 14 injections in 19 control patients (74%) (P ¼ 0.73). No significant association could be found between preoperative corticosteroid injection and postoperative SSIs or WHPs in patients with corticosteroid injections within 0 to 3 months before surgery [OR ¼ 0.36, 95% confidence interval (CI) 0.04-3.22], 0 to 6 months before surgery (OR ¼ 0.69, 95% CI 0.14-3.49), or any injection at all before surgery (OR ¼ 0.43, 95% CI 0.04-3.22) ( Table 2) .
Neither the values of the SSM, nor those of the Roland and Morris Disability Questionnaire, the pain intensity scale (numeric rating scale NRS), or the EuroQol-5D (EQ-5D-3L) scores were significantly different between the combined case group (SSI und WHP) compared with the matched control group (Table 3 ). 
DISCUSSION
We aimed to illuminate whether local corticosteroid injection before lumbar decompression surgery is potentially a clinically relevant independent risk factor for postoperative SSI or WHPs and to determine the minimal safe time interval between injection and surgery. Potential confounding factors were limited to a minimum through use of a large prospective multicenter national cohort and a matched case-control study design. We found no statistical difference in the calculated ORs between the group of patients who developed a SSI or WHP compared with the matched control group, no matter if the injections were made within 3 months, 6 months, or at any time point before surgery.
It is known that aseptic surgical techniques and prophylactic preoperative antibiotics are the most important measures to prevent SSIs. 14, 34 Further, several patient associated risk factors have been identified for SSI including diabetes and obesity. Other risk factors such as smoking are debatable. 24 It is questionable how strong local steroids would be a relevant risk factor for SSI or WHP, although the antiinflammatory as well as the immunosuppressive effects of cortisone are well known. [17] [18] [19] [20] This lack of information is even more surprising knowing that the systemic use of corticosteroids increases the rate of WHPs. 35 Intraoperative administration of epidural cortisone has been suggested to improve postoperative pain and to decrease the average length of hospital stay; however, an increase of postoperative epidural abscess formation after intraoperative epidural cortisone administration has been reported and therefore limits the advantages of the procedure. 22,36 -38 Our results concerning injections within 3 months before surgery are in concordance with the recent report by Seavey et al. 39 of a large sample size, but in discordance of those reported by Yang et al. 21 who clearly have found associations between time-interval of corticosteroid injections and the increase of SSIs. This might be because of several differences in the study designs and populations, such as a much smaller sample size in our cohort or inclusion of patients over 50 versus 65 years. However, the here presented results are based on a database with meticulous prospective data gathering methodology focusing on patients with a LSS on a multi-institutional level compared with the large but less detailed database in the study of Yang et al. 21 A major limitation of both studies is the definition of SSI. It is known that such can affect the reported rate of SSIs substantially. [40] [41] [42] [43] [44] [45] [46] In our study, we clearly focused on SSI or WHP severe enough to undergo surgery. But again, the indication for such a revision surgery was not standardized in the here used multicenter cohort. The here presented results have therefore to be interpreted in respect to this prominent limitation and also other kind of limitations. First, the relatively small number of patients who actually developed SSI or WHP might limit the statistical power, but as a rare event is being investigated, this limitation cannot be 
Key Points
Surgical site infections or wound healing problems are rare but serious complications after spinal surgery for LSS with an incidence of 2.4% (10 of 422 patients). A Swiss prospective multicenter cohort study was conducted to construct a case group and a matched control group according to age, sex, diabetes, and BMI to assess the risk of preoperative corticosteroid injection for surgical site infections or wound healing problems. Corticosteroid injections before lumbar spinal decompression surgery do not increase the risk of surgical site infections or wound healing problems.
